Sertraline compositions

Details Sertraline compositions Sertraline compositions

2007-03-06

2007-03-06

Barts, Samuel (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C564S428000, C514S657000

Reexamination Certificate

active

10851382

ABSTRACT:
An acid salt of sertraline, wherein the acid is citric acid, fumaric acid, malic acid, maleic acid, malonic acid, phosphoric acid, succinic acid, sulfuric acid, L-tartaric acid, HBr, acetic acid, benzoic acid, benzenesulfonic acid, ethanesulfonic acid, lactic acid, methanesulfonic acid or toluenesulfonic acid. Similarly, a solvate of sertraline HCl, wherein the solvent is methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, t-butanol, acetic acid, ethyl acetate, or propylene glycol.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4536518 (1985-08-01), Welch et al.
patent: 5059595 (1991-10-01), LeGrazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5248699 (1993-09-01), Sysko et al.
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5734083 (1998-03-01), Wilson et al.
patent: 6132420 (2000-10-01), Dionne et al.
patent: 6245357 (2001-06-01), Edgren et al.
patent: 6262308 (2001-07-01), Bigot
patent: 6270787 (2001-08-01), Ayer
patent: 6283953 (2001-09-01), Ayer et al.
patent: 6287295 (2001-09-01), Chen et al.
patent: 6333050 (2001-12-01), Wong et al.
patent: 6342249 (2002-01-01), Wong et al.
patent: 6365185 (2002-04-01), Ritschel et al.
patent: 6368626 (2002-04-01), Bhatt et al.
patent: 6375978 (2002-04-01), Kleiner et al.
patent: 6452054 (2002-09-01), Aronhime et al.
patent: 6495721 (2002-12-01), Schwartz et al.
patent: 6500987 (2002-12-01), Schwartz et al.
patent: 6517866 (2003-02-01), Am Ende et al.
patent: 2002/0048610 (2002-04-01), Cima et al.
patent: 2002/0183555 (2002-12-01), Schwartz et al.
patent: 2003/0023117 (2003-01-01), Aronhime et al.
patent: WO 00/21521 (2000-04-01), None
patent: WO 00/32551 (2000-06-01), None
patent: WO 01/32601 (2001-05-01), None
patent: WO 01/45692 (2001-06-01), None
patent: WO 01/90049 (2001-11-01), None
patent: WO 02/096859 (2002-12-01), None
Almarsson et al., “High-Throughput Surveys of Crystal Form Diversity of Highly Polymorphic Pharmaceutical Compounds”, Crystal Growth and Design, 3 (6), pp. 927-933 (2003).
Kim, Cherng-Ju, Controlled Release Dosage Form Design, Technomic Publishing Co., Lancaster, PA, pp. 231-238 (2000).

Affiliated with

Also associated with

Rating

Sertraline compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sertraline compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sertraline compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3775235